Free Trial
NASDAQ:YTEN

Yield10 Bioscience (YTEN) Stock Price, News & Analysis

Yield10 Bioscience logo

About Yield10 Bioscience Stock (NASDAQ:YTEN)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
78,164 shs
Market Capitalization
$257 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Yield10 Bioscience, Inc. is an agricultural biotechnology company focused on developing improved oilseed crops and sustainable products. The company’s primary platform is Camelina, an oilseed crop that can be engineered to produce useful oils and other compounds while supporting more sustainable agricultural and industrial applications.

Yield10 has developed Camelina traits intended to improve crop yield, oil composition and tolerance to environmental stresses. Its research programs have included Camelina varieties designed to produce omega-3 oils, including EPA and DHA, as well as oils that may serve as feedstocks for biofuels, bioplastics and other renewable products.

The company was formerly known as Metabolix, Inc. and adopted the Yield10 Bioscience name as its strategy shifted toward crop biotechnology and the development of sustainable agricultural products. Its research and commercialization efforts have been directed primarily at markets in North America, although the potential applications of its technology extend to global food, feed, fuel and industrial markets.

AI Generated. May Contain Errors.

Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

YTEN Stock News Headlines

Yield10 Bioscience Files for Chapter 11 Bankruptcy
Fox News: Wall Street Can Seize Your Retirement
Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution, Cede and Company, not the individual investor. If a brokerage collapses and customer securities were pledged as collateral, secured creditors can legally come before account holders. Physical gold held in a self-directed IRA is registered directly to you, with no clearinghouse or central institution holding its title.tc pixel
See More Headlines

YTEN Stock Analysis - Frequently Asked Questions

Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its quarterly earnings data on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) earnings per share (EPS) for the quarter, topping the consensus estimate of ($15.60) by $3.84. The specialty chemicals company earned $0.09 million during the quarter, compared to analysts' expectations of $0.22 million.

Shares of Yield10 Bioscience reverse split on the morning of Friday, May 3rd 2024.The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include FuelCell Energy (FCEL), Advanced Micro Devices (AMD), Viking Therapeutics (VKTX), Canopy Growth (CGC), NIO (NIO), Delta Air Lines (DAL) and Micron Technology (MU).

Company Calendar

Last Earnings
11/09/2021
Today
10/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Food Products
Sub-Industry
Agricultural Products & Services
Current Symbol
NASDAQ:YTEN
CIK
1121702
Employees
30
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($26.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.45 million
Net Margins
N/A
Pretax Margin
-1,693.60%
Return on Equity
N/A
Return on Assets
-296.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.16
Quick Ratio
0.16

Sales & Book Value

Annual Sales
$60 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($4.97) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
734,000
Free Float
689,000
Market Cap
$257 thousand
Optionable
Not Optionable
Beta
1.48

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:YTEN) was last updated on 10/12/2026 by MarketBeat.com Staff.
From Our Partners